API SUPPLIERS

API Suppliers

1

US DMFs Filed

0

CEP/COS Certifications

0

JDMFs Filed

0

EU WC

0

Listed Suppliers

1

API REF. PRICE (USD / KG)

0

API Market Place

0

INTERMEDIATES

0

DOSSIERS // FDF

USA (Orange Book)

0

Europe

0

Canada

0

Australia

0

South Africa

0

Uploaded Dossiers

0

GLOBAL SALES (USD Million)

U.S. Medicaid

0

Annual Reports

0

FDF Market Place

0

EXCIPIENTS

0

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

0

News

9

REF STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

0

SERVICES

0

Also known as: 944396-07-0, Nvp-bkm120, Bkm120, 5-(2,6-dimorpholinopyrimidin-4-yl)-4-(trifluoromethyl)pyridin-2-amine, Nvp-bkm-120, Bkm-120

Molecular Formula

C₁₈H₂₁F₃N₆O₂

Molecular Weight

410.4 g/mol

InChI Key

CWHUFRVAEUJCEF-UHFFFAOYSA-N

FDA UNII

0ZM2Z182GD

Buparlisib is an orally bioavailable specific oral inhibitor of the pan-class I phosphatidylinositol 3-kinase (PI3K) family of lipid kinases with potential antineoplastic activity. Buparlisib specifically inhibits class I PI3K in the PI3K/AKT kinase (or protein kinase B) signaling pathway in an ATP-competitive manner, thereby inhibiting the production of the secondary messenger phosphatidylinositol-3,4,5-trisphosphate and activation of the PI3K signaling pathway. This may result in inhibition of tumor cell growth and survival in susceptible tumor cell populations. Activation of the PI3K signaling pathway is frequently associated with tumorigenesis. Dysregulated PI3K signaling may contribute to tumor resistance to a variety of antineoplastic agents.

1 2D Structure

Buparlisib

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

5-(2,6-dimorpholin-4-ylpyrimidin-4-yl)-4-(trifluoromethyl)pyridin-2-amine

2.1.2 InChI

InChI=1S/C18H21F3N6O2/c19-18(20,21)13-9-15(22)23-11-12(13)14-10-16(26-1-5-28-6-2-26)25-17(24-14)27-3-7-29-8-4-27/h9-11H,1-8H2,(H2,22,23)

2.1.3 InChI Key

CWHUFRVAEUJCEF-UHFFFAOYSA-N

2.1.4 Canonical SMILES

C1COCCN1C2=NC(=NC(=C2)C3=CN=C(C=C3C(F)(F)F)N)N4CCOCC4

2.2 Other Identifiers

2.2.1 UNII

0ZM2Z182GD

2.3 Synonyms

2.3.1 MeSH Synonyms

1. Bkm120

2. Nvp-bkm120

2.3.2 Depositor-Supplied Synonyms

1. 944396-07-0

2. Nvp-bkm120

3. Bkm120

4. 5-(2,6-dimorpholinopyrimidin-4-yl)-4-(trifluoromethyl)pyridin-2-amine

5. Nvp-bkm-120

6. Bkm-120

7. 1202777-78-3

8. Bkm 120

9. Buparlisib (bkm120)

10. Nvp-bkm 120

11. Bkm120 (nvp-bkm120, Buparlisib)

12. 5-(2,6-dimorpholin-4-ylpyrimidin-4-yl)-4-(trifluoromethyl)pyridin-2-amine

13. Bkm-120nx

14. Bkm120-nx

15. 5-[2,6-di(morpholin-4-yl)pyrimidin-4-yl]-4-(trifluoromethyl)pyridin-2-amine

16. 0zm2z182gd

17. Chembl2017974

18. Chebi:71954

19. 944396-07-0 (free Base)

20. 2-pyridinamine,5-(2,6-di-4-morpholinyl-4-pyrimidinyl)-4-(trifluoromethyl)-

21. 5-[2,6-di(4-morpholinyl)-4-pyrimidinyl]-4-(trifluoromethyl)-2-pyridinamine.

22. Buparlisib [inn]

23. Buparlisib [usan:inn]

24. Unii-0zm2z182gd

25. Bkm 120nx

26. 5-[2,6-di(4-morpholinyl)-4-pyrimidinyl]-4-(trifluoromethyl)-2-pyridinamine

27. Sd5

28. Buparlisib; Bkm120

29. 3sd5

30. Buparlisib (usan/inn)

31. Buparlisib [usan]

32. Buparlisib [who-dd]

33. Mls006010984

34. Schembl146956

35. Gtpl7878

36. Bkm120,nvp-bkm120

37. Ammd00049

38. Bkm-120 (pi3k)

39. Dtxsid50241486

40. Ex-a189

41. Hms3295i15

42. Hms3655d16

43. Bkm120 (nvp-bkm120)

44. Bkm120 - Nvp-bkm120

45. Bdbm50380363

46. Mfcd18251596

47. Nsc754353

48. Nsc799370

49. S2247

50. Zinc43154039

51. 2-pyridinamine, 5-(2,6-di-4-morpholinyl-4-pyrimidinyl)-4-(trifluoromethyl)-

52. 5-(2,6-di-4-morpholinyl-4-pyrimidinyl)-4-(trifluoromethyl)-2-pyridinamine

53. Akos016005372

54. Am85983

55. Bcp9001011

56. Ccg-264954

57. Cs-0089

58. Db11666

59. Nsc-754353

60. Nsc-799370

61. Sb16577

62. Ncgc00262604-01

63. Ncgc00262604-08

64. Ac-32077

65. Ac-35575

66. As-40568

67. Hy-70063

68. Smr004702786

69. Db-079882

70. Ft-0755923

71. Sw218149-2

72. A25436

73. D10584

74. A892274

75. J-516601

76. Brd-k42191735-001-01-2

77. Q25100534

78. 4-(trifluoromethyl)-5-(2,6-dimorpholinopyrimidin-4-yl)pyridin-2-amine

79. 5-(2,6-di-4-morpholinyl-4-pyrimidinyl)-4-trifluoromethylpyridin-2-amine

80. 5-(2,6-di-morpholin-4-yl-pyrimidin-4-yl)-4-trifluoromethyl-pyridin-2-ylamine

2.4 Create Date

2007-08-09

3 Chemical and Physical Properties

Molecular Formula	C₁₈H₂₁F₃N₆O₂
Molecular Weight	410.4 g/mol
XLogP3	1.5
Hydrogen Bond Donor Count	1
Hydrogen Bond Acceptor Count	11
Rotatable Bond Count	3
Exact Mass	410.16780842 g/mol
Monoisotopic Mass	410.16780842 g/mol
Topological Polar Surface Area	89.6 Å²
Heavy Atom Count	29
Formal Charge	0
Complexity	530
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1